Ultragenyx Pharmaceutical Inc. (RARE) stock
RARENasdaqPharmaceutical PreparationsFiscal year ends December 31
$16.70+0.80 (+5.03%)
Close on Nov 17, 2026Market cap $1.65BP/E –Yield –
Ultragenyx Pharmaceutical EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?